Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine

Valérie Daugé, Françoise Beslot, Toshimitsu Matsui, Bernard Pierre Roques

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Cholecystokinin2 (CCK2) receptor-deficient mice were used to analyze the in vivo function of CCK2 receptor and especially the incidence of this gene invalidation on enkephalinergic and dopaminergic systems. Hyperlocomotor activity of CCK2 receptor-deficient mice was suppressed by a selective D2 antagonist but not by a D1 antagonist. Injection of amphetamine induced a hyperlocomotor activity in both groups of mice while mutant mice were less sensitive to cocaine. Administration of 6 mg/kg of morphine once every 2 days for 5 days significantly (P < 0.05) enhanced motor activity the last day compared to the first day, only in CCK2 receptor-deficient mice. These results emphasize the role of CCK2 receptors in counteracting the effects of dopaminergic systems and suggest that CCK2 receptor invalidation could lead to a slight behavioral sensitization.

Original languageEnglish
Pages (from-to)41-44
Number of pages4
JournalNeuroscience Letters
Volume306
Issue number1-2
DOIs
StatePublished - 22 Jun 2001
Externally publishedYes

Keywords

  • Amphetamine
  • Cholecystokinin receptor-deficient mice
  • Cocaine
  • Dopamine antagonists
  • Morphine
  • Sensitization

Fingerprint

Dive into the research topics of 'Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine'. Together they form a unique fingerprint.

Cite this